The Protease Inhibitor Amprenavir Protects against Pepsin-Induced Esophageal Epithelial Barrier Disruption and Cancer-Associated Changes

Gastroesophageal reflux disease (GERD) significantly impacts patient quality of life and is a major risk factor for the development of Barrett’s esophagus (BE) and esophageal adenocarcinoma (EAC). Proton pump inhibitors (PPIs) are the standard-of-care for GERD and are among the most prescribed drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaine-Sauer, Simon, Samuels, Tina L., Yan, Ke, Johnston, Nikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095080/
https://www.ncbi.nlm.nih.gov/pubmed/37047737
http://dx.doi.org/10.3390/ijms24076765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095080/
https://www.ncbi.nlm.nih.gov/pubmed/37047737
http://dx.doi.org/10.3390/ijms24076765

Ejemplares similares